Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Reconstituted High Density Lipoprotein, a Versatile Drug Delivery Nanoplatform for Tumor Therapy

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: WANG, Wei (China Pharmaceutical University, Pharmaceutics, Nanjing, China)
  • Co-author(s): Wei Wang: Pharmaceutics, China Pharmaceutical University, Nanjing, China
    Fangrong Zhang: Pharmaceutics, China Pharmaceutical University, Nanjing, China
    Jianping Zhou: Pharmaceutics, China Pharmaceutical University, Nanjing, China
  • Abstract:

    Backgrounds

    Reconstituted high density lipoprotein (rHDL) represents an excellent biomimetic tool for targeted delivery of chemical/biological agents (chemotherapeutics, DNA, siRNAs, photosensitizers, etc.) into various tumor cells. These rHDL nanoparticles offer many advantages for antitumor drug delivery over their native counterparts while..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses